Mission Bio
6 known investors
Mission Bio develops single-cell biology tools and platforms for researchers and clinicians to enable precision medicine discovery and cancer treatment. The company serves the biomedical research and clinical diagnostics market.
Founders & leadership
AS
Adam SciambiinChief Technology Officer and Co-founder
Investors · 6
Competitors · 3
by search overlap
IDbyDNA105 shared keywordsScalable, high throughput DNA sequencing platforms.
Oup101 shared keywordsOxford University Press publishes research, educational, and reference materials, including reports on reading and children's learning, and reference resources such as its dictionary "Word of the Day." It serves readers, educators, and learners across a wide range of subjects worldwide.
10x Genomics 1-color67 shared keywords10x Genomics offers single cell analysis technology, including its Flex assay and Flex Apex product, which use probe-based chemistry and plate-based multiplexing to profile fresh, frozen, and FFPE samples for researchers. The tools support applications in cancer, immunology, and neuroscience, enabling gene expression and multiomic profiling of cell surface protein, intracellular protein, and CRISPR guides.
Companies competing with Mission Bio for the same Google search keywords, organic and paid, via search-intersection analysis.
Frequently asked questions
- What does Mission Bio do?
- Mission Bio develops single-cell biology tools and platforms for researchers and clinicians to enable precision medicine discovery and cancer treatment. The company serves the biomedical research and clinical diagnostics market.
- Who founded Mission Bio?
- Mission Bio was founded by Adam Sciambi.
- Who are Mission Bio's investors?
- Mission Bio's investors include Cota Capital, Fusion, Green Park & Golf Ventures, Keiretsu Forum, Mighty Capital, Foothill Ventures.